APA (7th ed.) Citation

M, L., T, B., MMT, v. L., ML, S., F, F., J, M., . . . R, D. (2018). Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. Nature biomedical engineering, 2(8), 623. https://doi.org/10.1038/s41551-018-0281-3

Chicago Style (17th ed.) Citation

M, Lameijer, et al. "Author Correction: Efficacy and Safety Assessment of a TRAF6-targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-human Primates." Nature Biomedical Engineering 2, no. 8 (2018): 623. https://doi.org/10.1038/s41551-018-0281-3.

MLA (9th ed.) Citation

M, Lameijer, et al. "Author Correction: Efficacy and Safety Assessment of a TRAF6-targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-human Primates." Nature Biomedical Engineering, vol. 2, no. 8, 2018, p. 623, https://doi.org/10.1038/s41551-018-0281-3.